A federal judge has overturned childhood vaccination policies implemented earlier this year by the U.S. Department of Health and Human Services, ruling that officials under HHS Secretary Robert F. Kennedy Jr. acted unlawfully when they issued new guidelines in January. U.S. District Judge Brian Murphy found that the agency had "disregarded" established scientific methods and "undermined the integrity of its actions."
The struck-down guidelines had reduced the number of recommended childhood vaccinations, covering 11 diseases instead of the 16 previously recommended. They also downgraded immunization recommendations for rotavirus, influenza, and hepatitis A. Murphy's ruling, as reported by Healthline, additionally blocked Kennedy's 13 appointees to the Advisory Committee on Immunization Practices, finding the panel had been constituted in violation of federal law requiring it to be "fairly balanced and free of inappropriate influence."
The decision has had immediate ripple effects. ACIP meetings scheduled to discuss potential changes to COVID-19 vaccine recommendations were postponed following the March 16 ruling. The judge also placed a hold on votes taken by ACIP members since June, including a December decision to roll back the longstanding recommendation that newborns receive a first dose of the hepatitis B vaccine within 24 hours of birth. The Trump administration is expected to appeal.
The lawsuit was brought by the American Academy of Pediatrics and other major medical organizations. "Today's ruling is a historic and welcome outcome for children, communities, and pediatricians everywhere," said AAP president Andrew Racine, MD. He called the decision "a critical step to restoring scientific decision-making to federal vaccine policy that has kept children healthy for years."
The case underscores an intensifying legal battle over federal health policy. At its core is a fundamental question: whether longstanding, science-based processes for evaluating vaccine safety and efficacy can be overridden by political appointees. For now, the court has sided firmly with the medical establishment, but an appeal could bring the issue before higher courts in the coming months.
